Wells Fargo’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-8
| Closed | -$180 | – | 7376 |
|
2023
Q2 | $180 | Hold |
8
| – | – | ﹤0.01% | 6422 |
|
2023
Q1 | $96 | Hold |
8
| – | – | ﹤0.01% | 6625 |
|
2022
Q4 | $36 | Hold |
8
| – | – | ﹤0.01% | 6785 |
|
2022
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 7426 |
|
2022
Q2 | $0 | Sell |
8
-682
| -99% | – | ﹤0.01% | 7500 |
|
2022
Q1 | $13K | Sell |
690
-410
| -37% | -$7.73K | ﹤0.01% | 5839 |
|
2021
Q4 | $39K | Sell |
1,100
-5,622
| -84% | -$199K | ﹤0.01% | 5616 |
|
2021
Q3 | $494K | Buy |
6,722
+5,459
| +432% | +$401K | ﹤0.01% | 4409 |
|
2021
Q2 | $176K | Buy |
1,263
+1,078
| +583% | +$150K | ﹤0.01% | 4782 |
|
2021
Q1 | $54K | Buy |
+185
| New | +$54K | ﹤0.01% | 5433 |
|